# FDA Inspection 1122664 - Loyola University Medical Center, Cardinal Bernadine Cancer - February 06, 2020

Source: https://www.keypedia.com/records/fda_inspections/loyola-university-medical-center-cardinal-bernadine-cancer/7d260fb6-45d9-402e-8838-e31e75af2211
Source feed: FDA_Inspections

> FDA Inspection 1122664 for Loyola University Medical Center, Cardinal Bernadine Cancer on February 06, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122664
- Company Name: Loyola University Medical Center, Cardinal Bernadine Cancer
- Inspection Date: 2020-02-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/loyola-university-medical-center-cardinal-bernadine-cancer/46931cbb-8346-4a39-b194-aacdb9778d59

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d